Company profile: Bigfoot Biomedical
1.1 - Company Overview
Company description
- Provider of diabetes management solutions for insulin-requiring individuals, offering the Bigfoot Unity system that integrates with the FreeStyle Libre 2 sensor to provide insulin dose recommendations for multiple-daily-injection users, the Bigfoot Unity Mobile App for dosing and glucose data, and the Bigfoot Clinic Hub for clinician data review; adheres to security and privacy laws, including HIPAA.
Products and services
- Bigfoot Unity Diabetes Management System: Sensor-integrated platform that integrates with FreeStyle Libre 2 to deliver insulin dose recommendations for multiple daily injections using simple design, cloud connectivity, and human-centered automation
- Bigfoot Unity Mobile App: Patient-facing companion that works with the Bigfoot Unity System to present glucose monitoring data and generate insulin dosing recommendations for people using multiple daily injections
- Bigfoot Clinic Hub: Provider-facing portal enabling healthcare professionals to access and review patient data from the Bigfoot Unity system supporting clinical visibility into insulin-requiring diabetes care
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Bigfoot Biomedical
Protomer
HQ: United States
Website
- Description: Provider of pre-clinical biotechnology R&D focused on metabolic diseases, developing glucose-responsive insulin receptor agonist therapeutics and the Molecular Evolution of Peptide Sensors (MEPS) platform for creating therapeutic peptides and proteins with tunable, small-molecule-controlled activity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Protomer company profile →
TypeZero
HQ: United States
Website
- Description: Provider of digital health and personalized medicine focused on the treatment and management of diabetes, leveraging more than 10 years of clinical trials, research, and innovation to develop the inControl Diabetes Management Platform to improve and simplify the lives of people with diabetes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TypeZero company profile →
Osler Diagnostics
HQ: United Kingdom
Website
- Description: Provider of portable, low-cost, quick, and easy-to-use lab-quality diagnostics, featuring the Osler Origin 'portable lab' for a wide range of tests across healthcare settings. Offers lab-in-your-hand technology with microfluidic sample preparation and electrochemical biosensing, HemaTap sample addition for simplified cartridges, and a comprehensive test menu.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Osler Diagnostics company profile →
Sano
HQ: United States
Website
- Description: Provider of a small wearable sensor that continuously captures and transmits blood chemistry data to virtually any device and liberates this data to a third-party development and analytical platform called the 'API for the bloodstream'.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sano company profile →
CytoTools
HQ: Germany
Website
- Description: Provider of unique biotechnology therapies derived from fundamental biology research on cell growth and programmed cell death, designed to treat the causes of disease rather than the symptoms.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CytoTools company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Bigfoot Biomedical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Bigfoot Biomedical
2.2 - Growth funds investing in similar companies to Bigfoot Biomedical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Bigfoot Biomedical
4.2 - Public trading comparable groups for Bigfoot Biomedical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →